Class II Invariant Chain HCV Vaccine Study
NCT03688061
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C
Interventions
BIOLOGICAL:
ChAd3-hliNSmut
BIOLOGICAL:
MVA-hliNSmut
Sponsor
University of Oxford
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]